Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 34

Results For "daily"

442 News Found

Mandaviya chairs high level meeting to review COVID-19 status
Policy | June 24, 2022

Mandaviya chairs high level meeting to review COVID-19 status

The Minister directed officials to continue to focus on surveillance and on Whole Genome Sequencing to scan for any possible mutation and also directed for monitoring hospitalizations due to COVID-19 and SARI/ILI cases


Rivaroxaban approved in Japan for patients with PAD after revascularisation
Drug Approval | June 24, 2022

Rivaroxaban approved in Japan for patients with PAD after revascularisation

It´s the first trial to demonstrate the benefits of dual pathway inhibition


Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections
News | June 22, 2022

Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections

COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.


Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
News | June 16, 2022

Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India

Glenmark is the first company in India to market the innovative FDC of Indacaterol


MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
News | June 07, 2022

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients


BGS Gleneagles launches its refurbished advanced emergency & trauma center
Healthcare | June 02, 2022

BGS Gleneagles launches its refurbished advanced emergency & trauma center

120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care


Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis
Biotech | May 27, 2022

Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis

Data from the three studies formed the basis of the company's application for approval by regulatory agencies


Fitelo unveils new branding after Pre-Series A fund-raise
Startup | May 25, 2022

Fitelo unveils new branding after Pre-Series A fund-raise

Each member of Fitelo's team of experts gives highly personalized attention and recommendations to their clients ensuring they reach their fitness goals holis


Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool
Digitisation | May 24, 2022

Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool

The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs


Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections
News | May 24, 2022

Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections

'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)